Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 11:31 PM
Study NCT ID:
NCT00068393
Status:
COMPLETED
Last Update Posted:
2023-07-07
First Post:
2003-09-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2009-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2003-09-10
First Submit QC Date:
None
Study First Post Date:
2003-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-11-30
Results First Submit QC Date:
None
Results First Post Date:
2013-01-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-21
Last Update Post Date:
2023-07-07
Last Update Post Date Type:
ACTUAL